Have you ever heard of Lemtrada, the revolutionary drug that’s been making headlines lately? If so, you might be wondering who makes Lemtrada and what goes into the creation of this life-changing treatment. In this article, we’ll explore the history of Lemtrada and the company that manufactures it, as well as the science and technology behind the drug’s production. From the early days of research to the current state of the manufacturing process, we’ll dive into the fascinating world of Lemtrada to uncover the truth behind this groundbreaking medicine.
Lemtrada (alemtuzumab) is a prescription medication used to treat relapsing forms of multiple sclerosis (MS). It is manufactured by Genzyme, a Sanofi company. Lemtrada works by targeting specific cells of the immune system that are involved in MS. It is a monoclonal antibody that is administered as an intravenous (IV) infusion.
When treating MS with Lemtrada, two 12-mg infusions are given two days apart and then three more infusions are given one year later. Common side effects may include headache, fever, nausea, and injection site reactions.
Who Makes Lemtrada?
Lemtrada (alemtuzumab) is an injectable prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS). It is manufactured by Sanofi Genzyme, the specialty care global business unit of Sanofi.
What is Lemtrada?
Lemtrada is a monoclonal antibody (a type of protein) that works by targeting a protein called CD52 that is found on the surface of white blood cells. It interferes with the growth of a certain type of white blood cells called lymphocytes, which play a role in the immune system’s attack on the nervous system in people with MS.
How Does Lemtrada Work?
Lemtrada works by blocking the action of CD52. By blocking CD52, Lemtrada helps to prevent the immune system from attacking the nervous system. This can reduce the frequency and severity of MS relapses and slow down the progression of the disease.
What are the Possible Side Effects of Lemtrada?
Common side effects of Lemtrada include:
- Headache
- Fever
- Fatigue
- Nausea
- Pain at injection site
Less common side effects may include:
- Inflammation of the pancreas (pancreatitis)
- Inflammation of the liver (hepatitis)
- Decreased white blood cell count
It is important to discuss all potential side effects with your doctor before taking Lemtrada.
Few Frequently Asked Questions
Q1. Who Makes Lemtrada?
A1. Lemtrada is a brand-name prescription medication manufactured by Sanofi Genzyme. It was approved by the United States Food and Drug Administration (FDA) in November 2014 for the treatment of relapsing forms of multiple sclerosis (MS). Lemtrada is an immunomodulator and is administered by intravenous infusion over two consecutive days for a total of 12 infusions. It is believed to reduce inflammation and help repair damage to the myelin sheath, which protects nerve cells. Lemtrada was developed by Sanofi Genzyme’s research and development team and is marketed by Sanofi Genzyme in the United States.
Q2. What is Lemtrada used to Treat?
A2. Lemtrada is used to treat relapsing forms of multiple sclerosis (MS). MS is a chronic autoimmune disorder of the central nervous system (CNS) that causes inflammation and damage to the myelin sheath, which protects nerve cells. Lemtrada is believed to reduce inflammation and help repair damage to the myelin sheath. It is administered by intravenous infusion over two consecutive days for a total of 12 infusions. It is important to note that Lemtrada is not a cure for MS and should be used in combination with other MS treatments.
Q3. How Does Lemtrada Work?
A3. Lemtrada works by targeting the immune system to reduce inflammation and help repair damage to the myelin sheath. It does this by blocking the activity of certain white blood cells (lymphocytes) that attack the myelin sheath. This helps to reduce inflammation and helps to repair the damaged sheath. Lemtrada also helps to reduce the number of MS relapses.
Q4. What are the Side Effects of Lemtrada?
A4. The most common side effects of Lemtrada include injection site reactions, flu-like symptoms, headache, and upper respiratory tract infections. More serious side effects of Lemtrada include an increased risk of infection and autoimmune disorders. Before taking Lemtrada, it is important to discuss the potential side effects with a doctor.
Q5. What is the Cost of Lemtrada?
A5. The cost of Lemtrada varies depending on insurance coverage and other factors. The average cost of a 12-infusion course of Lemtrada is approximately $90,000. Some insurance companies may cover a portion of the cost, while others may not. It is important to discuss the cost of Lemtrada with a doctor and insurance provider before starting treatment.
Q6. What is the Dosage for Lemtrada?
A6. The recommended dosage for Lemtrada is 12 intravenous infusions given over two consecutive days. It is important to note that the infusions must be given at least one month apart. The dosage for each infusion is 12 mg of Lemtrada per kg of body weight. It is important to follow the doctor’s instructions and to not change the dosage without consulting a doctor.
In conclusion, Lemtrada is an innovative drug that has revolutionized the treatment of Multiple Sclerosis. It is developed by Sanofi Genzyme, a subsidiary of Sanofi, a leading global biopharmaceutical company that specializes in bringing innovative treatments to people around the world. It is a testament to Sanofi’s commitment to help patients with rare and disabling diseases. Lemtrada has been proven to be effective in treating multiple sclerosis, and its availability has greatly improved the quality of life of patients living with this condition.